These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8859780)
1. Superior cytotoxic potency of mitoxantrone in interaction with DNA: comparison with that of daunorubicin. Fukushima T; Kawai Y; Nakayama T; Yamauchi T; Yoshida A; Urasaki Y; Imamura S; Kamiya K; Tsutani H; Ueda T; Nakamura T Oncol Res; 1996; 8(2):95-100. PubMed ID: 8859780 [TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia. Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494 [TBL] [Abstract][Full Text] [Related]
3. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells. Wu YH; You Y; Chen ZC; Zou P Acta Biochim Pol; 2008; 55(4):673-80. PubMed ID: 19093040 [TBL] [Abstract][Full Text] [Related]
4. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells. Capranico G; Soranzo C; Zunino F Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414 [TBL] [Abstract][Full Text] [Related]
5. Effects of daunorubicin on cell growth, cell cycle and induction of apoptosis in HL-60 cells. Chikayama S; Kimura S; Kobayashi Y; Abe T; Maekawa T; Kondo M Haematologia (Budap); 1998; 29(2):115-21. PubMed ID: 9728803 [TBL] [Abstract][Full Text] [Related]
6. Effect of mitoxantrone on DNA polymerase of Ehrlich ascites carcinoma cells. Xian LJ; Li HX; Liu ZC; Pan QC Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):356-8. PubMed ID: 10375784 [TBL] [Abstract][Full Text] [Related]
7. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390 [TBL] [Abstract][Full Text] [Related]
8. The interaction of daunorubicin and mitoxantrone with the red blood cells of acute myeloid leukemia patients. Marczak A; Wrzesień-Kuś A; Krykowski E; Robak T; Júźwiak Z Cell Mol Biol Lett; 2003; 8(4):885-90. PubMed ID: 14668911 [TBL] [Abstract][Full Text] [Related]
9. [Features of the interaction of antitumor mitoxantrone compounds with sarcoma 45 tumor DNA]. Babaian IuS Biofizika; 1991; 36(1):35-8. PubMed ID: 1854828 [TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Côme MG; Skladanowski A; Larsen AK; Laurent G Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059 [TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells. Skladanowski A; Konopa J Br J Cancer; 2000 Apr; 82(7):1300-4. PubMed ID: 10755405 [TBL] [Abstract][Full Text] [Related]
13. Evidence for inhibition of growth related to compromised DNA synthesis in the interaction of daunorubicin with H-35 rat hepatoma. Munger C; Ellis A; Woods K; Randolph J; Yanovich S; Gewirtz D Cancer Res; 1988 May; 48(9):2404-11. PubMed ID: 3356005 [TBL] [Abstract][Full Text] [Related]
14. Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells. Fukushima T; Ueda T; Uchida M; Nakamura T Int J Hematol; 1993 Apr; 57(2):121-30. PubMed ID: 8494991 [TBL] [Abstract][Full Text] [Related]
15. Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death. Gieseler F; Nüssler V; Brieden T; Kunze J; Valsamas S Int J Clin Pharmacol Ther; 1998 Jan; 36(1):25-8. PubMed ID: 9476145 [TBL] [Abstract][Full Text] [Related]
16. [Effect of daunorubicin and cytarabine on cell line NB4]. Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202 [TBL] [Abstract][Full Text] [Related]
17. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. Masquelier M; Vitols S Biochem Pharmacol; 2004 May; 67(9):1639-46. PubMed ID: 15081863 [TBL] [Abstract][Full Text] [Related]
18. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333 [TBL] [Abstract][Full Text] [Related]
19. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566 [TBL] [Abstract][Full Text] [Related]
20. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines. Taatjes DJ; Fenick DJ; Koch TH Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]